CXCL9 emerges as a promising biomarker for primary Sjögren’s syndrome with extra-glandular manifestations
Achieving persistent low disease activity or remission crucial in preventing atherosclerosis progression in early rheumatoid arthritis
Secreted phosphoprotein 1 emerges as a promising biomarker for identifying rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis patients
